:

Guidelines for authors

Manuscripts must be in Persian with English title and abstract or in English with Persian title and abstract. It is essential to follow the rules of correct language. Manuscripts poor in writing skill will not be processed for scientific reviewing. Authors must follow the “instructions for authors” carefully. Manuscripts in inappropriate format may be rejected without being reviewed. All articles must comprise a title, an abstract, main body and references. Each part must be prepared precisely according to the following rules and regulations.

Title page (in both English and Persian): The title page must include the title of the paper, the authors’ complete names, affiliations and postal as well as electronic addresses. Papers must have only one corresponding author. The title must be written in bold letters with font size 14.

Abstract: Every paper must have two abstracts, one in Persian and one in English. The abstract must include important findings of the author(s) and the contribution to the field. It must not exceed 250 Persian words, or 200 English words. The Persian abstract must be written by B-Zar 10 font and the English abstract by Times new Roman 10 font.

Keywords: The abstract, Persian or English, must be followed by 5 keywords in the same language. These words must not have been mentioned in the Title.

The above mentioned part must be ordered in the following manner: Persian title page, Persian abstract, Persian keywords, English title page, English abstract and English keywords.

Main body: The main body of the manuscript must include an introduction, materials and methods, results and discussion, and an optional acknowledgements part. The manuscript must prepared by the “Microsoft Office Word 2003”. All Persian words in the main body of the manuscript must be written by B-Zar 12 font and all English words by Times new Roman 11 font. Line-spacing must be adjusted to 1 cm. The headings must be written by font size 12 and in bold letters. The subheadings must be written by font size 11 and in bold letters. 

Footnotes and explanations of figures and tables in Persian manuscripts must be written both in Persian and in English. Persian words must be written by B-Zar 10 and English words by Times new Roman 10.

Literature citations and references: To cite references in the text of the main body, the following style must be observed. The name of the author and the year of the publication must be written in parentheses, e.g. (Broughton, 2012). In case the references which are cited have two authors, the names of the authors must be separated by “&”, e.g. (Lee & Mao, 2012). Finally, if more than two authors have cooperated in the compilation of the paper cited, only the name of the first author is mentioned, followed by “et al.”, e.g. (Friedman et al., 1999; Kopen et al., 2002).

The references part at the end of the paper must be organized in the following way.

Samples for published articles:

Tuhkanen, A.L., Agren, L.M., Tammi, M.I. and Tammi, R.H. 1999. CD44 expression marks the onset of keratinocyte stratification and mesenchymal maturation into fibrous dermis in fetal human skin. – The J. Histochem. and Cytochem. 47: 1617-1624.

Samples for published books:

Taiz, L. and Zeiger, E. 2010. Plant Physiology. – Sinauer Associates, Los Angeles, 322 pp.

Samples for referencing to certain pages of a book:

Metcalfe, C.R. and Chalk, L. 1979. Anatomy of the Dicotyledons. – Oxford Science Publications, Oxford. pp: 222-249.

Samples of referencing to certain chapters of a book:

Browicz, K. and Zielinski, J. 1977. Rhamnus L. – In: Rechinger, K.H. (ed.), Flora Iranica. vol. 125: 14-25. – Akad. Druck- und Verlagsanstalt, Graz.

Huber-Morath, A. 1967. Gypsophila L. – In: Davis, P.H. (ed.). Flora of Turkey and the East Aegean Islands 2: 149-171. – Edinburgh University Press, Edinburgh.

Samples of referencing to electronic references:

Thiers, B. 2015 continuously updated. Index herbariorum: A global directory of public herbaria and associated staff. New York Botanical Garden, Bronx, NY. Available from: http://sweetgum.nybg.org/ih/ [accessed 29 July 2015]

The International Plant Names Index. 2012+. Published on the Internet http://www.ipni.org [accessed 1 March 2016]

In the references part of the manuscript the complete name of the journals must not be mentioned; instead, the initials of the journals must be used. As an example, the following site has been used to refer to papers in botany and related sciences in order to cite the initials of the journals uniformly.

Bridson G.D.R., 2004: BPH-2. – Pittsburgh: Hunt Institute.

(BPH Online: http://fmhibd.library.cmu.edu/HIBD-DB/bpho/findrecords.php)

Complete papers, abstracts of the papers presented in conferences, theses or dissertations should not be used as references. In case necessary the mention of only one of these kinds of references may be permitted.

  • Figures and tables, together with their captions, must be prepared in a separate file and be numerated according to their occurrence in the main body. They should be of high quality and in their preparation colors and patterns which can be distinguishable in black and white printing must be used.
  • The scientific names of the taxa must be written in full, together with the name(s) of the author(s), when they appear for the first time. They must be written in the abbreviated form when they are repeated. It is recommended that they should be written in the full form when they are used in titles and abstracts.
  • The English abstract must reflect the contents of the Persian abstract or vice versa. This applies exactly to the captions of figures and tables. All English content must be checked by an expert of the English language. Papers in poor English will be rejected.
  •  All the authors must sign the copyright form and the corresponding author is responsible for presenting this to the journal.
  • Addressing the academic email of the corresponding author is preferable.
  • The authors hold the total responsibility for what they present in their papers.
  • The papers submitted to the journal will be processed for scientific review. The journal holds the rights to accept, reject, or edit them.
There are no submission fees, publication fees or page charges for this journal.The journal is compeletly open access.

Publication Ethics for Journal Authors and their responsibilities

All authors must warrant that their article is their own original work, which does not infringe the intellectual property rights of any other person or entity, and cannot be construed as plagiarizing any other published work, including their own previously published work.
  • Authorship of the Paper
The corresponding author must ensure all named co-authors consent to publication and to being named as a co-author. All persons who have made significant scientific or literary contributions to the work reported should be named as co-authors.
Where there are others who have participated in certain substantive aspects of the paper (e.g. language editing or medical writing), they should be recognized in the acknowledgements section.
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Only in exceptional circumstances will the Editor consider (at their discretion) the addition, deletion or rearrangement of authors after the manuscript has been submitted and the author must clearly flag any such request to the Editor.
All authors must agree with any such addition, removal or rearrangement. Authors take collective responsibility for the work.  Each individual author is accountable for ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
 
  • Affiliation
An institution must be quoted as the author's affiliation if the institution has made a necessary and material contribution to or provided a basis for the author's contribution to the manuscript. Employment, current educational activity and supervisory responsibility can be considered justification for crediting an institution as the author's affiliation.
All authors contributed must aware of the final version of the manuscript before submission. Page proofs for accepted manuscripts are sent via e-mail to the corresponding author. It is the corresponding author's responsibility to consult with co-authors regarding the proofs. 
  • Originality of the Paper
Authors should not submit previously published work, nor work which is based in substance on previously published work, either in part or whole. Authors must not submit a manuscript to more than one journal simultaneously.
 
  • Accuracy of the presented data and analyses
Authors of original research reports should present an accurate account of their performed project as well as an objective discussion of its significance. Original data should be represented accurately in the paper (either in the main body of the manuscript or as a supplementary section) with sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.
 
  • Plagiarism
Authors must appropriately cite all relevant publications. Information obtained privately, as in conversation, correspondence, or discussion with third parties, should not be used or reported in the author's work unless fully cited, and with the permission of that third party.
Plagiarism in its many forms-from ‘passing off’ another’s paper as the author’s own paper, to copying or paraphrasing substantial parts of another’s paper (without attribution), to claiming results from research conducted by others- constitutes unethical behavior and is unacceptable.
The “Nova Biologica Reperta” accepts all terms and conditions of COPE about plagiarism and in case, any attempt of evident plagiarism countermeasures by flowcharts and workflows determined in COPE.
Republishing is considered a case of plagiarism and the “Nova Biologica Reperta” journal strongly recommend authors to avoid submitting papers or variations of papers on studies that have already been published elsewhere in English or any local languages.
 
  • Hazards and Human, Animal and Plant Subjects.
If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript.
If the work involves the use of animal or human subjects, the author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) has approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
Authors must certify that the inclusion of endangered Animal or Plant species in their study is in compliance with regional and international conservation policies. Sampling specimens from protected areas should be legally permitted by relevant authorities and the legal license should be mentioned in the manuscript.
  • Photographs
It is not acceptable to enhance, obscure, move, remove, or introduce a specific feature within an image. Adjustments of brightness, contrast, or color balance are acceptable if and as long as they do not obscure or eliminate any information present in the original. Manipulating images for improved clarity is accepted, but manipulation for other purposes could be seen as scientific ethical abuse and will be dealt with accordingly. Photographs with identifiable human subjects are excepted as follows.
 
  • Photographs with Identifiable Human Subjects
In photographs, sonograms, CT scans, etc., the physical identification of a human subject should be masked whenever possible, unless a written permission to use the photograph which is directly obtained from the subject or his/her legal guardian prepared and presented to the journal. The permission note should be clearly stated in the manuscript in the proper place (either in the figure legend or the main body of the text).
 
  • Drugs, Devices and ready to use materials
The generic names, trademarks, models and manufacturers data(name, city and country of the origin) of drugs, devises and ready to use materials should be mentioned in the material and methods section.
 
  • Abbreviations
    Use only standard abbreviations which are internationally and/or nationally recognized and spell out all abbreviations at first use in the text followed by the abbreviation in parentheses. In the case of overall similarity between the abbreviated titles of two or more institutions, new abbreviations should be designated to differentiate the mentioned institutions adequately.
 
  • Role of Funding Sources 
 
Authors must acknowledge funding sources by identifying who provided financial support for the conduct of the research and/or preparation of the manuscript and to briefly describe the role (if any) of the funding sponsor in study design, collection, analysis, or interpretation of data, writing the manuscript, and the decision to submit the manuscript for publication. The role of funding sources should be noted both in the acknowledgment section of the manuscript and in the covering letter. If the funding source had no such involvement, the authors should so state.
 
  • Contributors 
    Authors must declare their individual contributions to the manuscript in the covering letter. All authors must have materially participated in the research and/or the manuscript preparation. Roles for each author should be described.
 
  • Conflict of Interest
Authors must declare any potential conflict of interest – be it professional or financial – which could be held to arise with respect to the article both in the main body of the manuscript and in the covering letterConflict of interest is defined as any financial or personal relationships with individuals or organizations, occurring within three (3) years of beginning the submitted work, which could inappropriately influence, or be perceived to have influenced the submitted research manuscript. Potential conflict of interest would include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications, registrations, and grants.
 
  • Acknowledgments 
    Authors must provide Acknowledgments which will be published in a separate section along with the manuscript to certify the roles of non-author contributors such as investors, financial providers and advisors. If there are no Acknowledgments, there should be no heading or acknowledgment statement.

Publication process after acceptance

 
Accepted Article Received in Production
When an accepted article is received, the corresponding author will receive an e-mail.
Proofs
Once the paper is typeset, the author will receive an e-mail notification with full instructions on how to provide proof corrections.

Please note that the author is responsible for all statements made in their work, including changes made during the editorial process; authors should check proofs carefully. Note that proofs should be returned within 48 hours from receipt of first proof.

Post Publication

Access and Sharing
When the article is published online:
• The author receives an e-mail alert.
• The link to the published article can be shared through social media.
• The author will have free access to the paper.
 


View: 1312 Time(s)   |   Print: 243 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)

© 2018 All Rights Reserved | Nova Biologica Reperta

Designed & Developed by : Yektaweb